MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Clinical features"

  • 2025 International Congress

    Expanding the Clinical Spectrum of Fejerman Syndrome: Insights from Video EEG and Long-Term Follow-Up

    M. Hull, M. Sudheendra, M. Gonzalez, B. Evans, D. Takacs, A. Katyayan (Houston, USA)

    Objective: We review the clinical spectrum of infants diagnosed with Fejerman syndrome, provide detailed phenomenology through video review and long-term outcomes Background: First described by…
  • 2025 International Congress

    Genetic and clinical spectrum of pediatric hyperkinetic movement disorders in a Spanish tertiary center

    JD. Ortigoza Escobar, B. Antomil Guerrero, L. Marti-Sanchez, D. Yubero, C. Xiol Viñas, A. Alcalá Sanmartín, C. Hernando Davalillo, J. Armstrong, L. Martorell (Barcelona, Spain)

    Objective: To investigate the genetic etiology of pediatric hyperkinetic movement disorders (PMDs), characterize their associated phenotypes, comorbidities, and neuroimaging findings, and evaluate the impact of…
  • 2025 International Congress

    Oculopalatal Myoclonus Secondary to Brainstem Hemorrhage: A Case Report

    S. Fu, U. Agarwal, T. Abu-Zahra, Z. Farzal (Detroit, USA)

    Objective: To present a case of oculopalatal myoclonus (OPM) secondary to brainstem hemorrhage. Background: OPM is an acquired syndrome characterized by synchronized pendular nystagmus with…
  • 2025 International Congress

    Retrospective series of adult-onset myoclonus presenting to an outpatient movement disorders clinic

    M. Hamed, K. Oh, D. Zarandi, M. Oluleye, A. Zaher, J. Elsaygh, S. Rizly, X. Ma, H. Ooi, H. Sarva, M. Salgado, D. Victor (Brooklyn, USA)

    Objective: To describe the phenomenology, etiology and treatment response in adults presenting to our clinic with myoclonus. Background: Myoclonus in the inpatient setting range often…
  • 2025 International Congress

    A Rare Case of Anti-Hu Opsoclonus-Myoclonus Syndrome after Immune Checkpoint Inhibitor Immunotherapy in a Patient with Small Cell Lung Cancer in Remission

    L. Hong, P. Atit, R. Patil, E. Sandberg, A. Makarova (Tampa, USA)

    Objective: To describe a case of anti-Hu/ANNA-1 Opsoclonus-Myoclonus syndrome (OMS) in a patient with small cell lung cancer (SCLC) after treatment with an immune checkpoint…
  • 2025 International Congress

    Uncommon Presentation of Moyamoya Disease (MMD): A Case of Negative Myoclonus

    S. Park (Daejeon, Republic of Korea)

    Objective: We describe a case of MMD in which the patient presented with negative myoclonus. Background: Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized…
  • 2025 International Congress

    Focal Lower Limb Myoclonus Heralding Adult Onset Fulminant SSPE

    S. Jha, S. Pendyala (Kolkata, India)

    Objective: We report a case adult onset fulminant SSPE with focal lower limb myoclonus as the predominant presenting movement disorder. Background: Myoclonus remains a defining…
  • 2025 International Congress

    A Standardised, Semi-automated Computational Approach to the Analysis of Electrophysiology in Orthostatic Myoclonus

    N. Jeyakumar, S. Nagaratnam, G. Jeyakumar, P. Becker, F. Chang, V. Fung (Westmead, Australia)

    Objective: We sought to develop a standardised, computationally tractable approach to the analysis of electrophysiology in orthostatic myoclonus by developing novel definition criteria for myoclonic…
  • 2025 International Congress

    Insights into Myoclonus Dystonia from an Indian movement disorder clinic

    F. Mustafa, A. Mudda, A. Agarwal, A. Srivastava, D. Garg, A. Garg (New Delhi, India)

    Objective: To describe the clinical profile, etiology and treatment profile of myoclonus dystonia patients attending a single movement disorder clinic. Background: Myoclonus-dystonia (MD) is a…
  • 2025 International Congress

    Deciphering differences in Functional Movement Disorders between Children and Adults

    D. Kalikavil Puthanveedu, A. Cherian (Thiruvananthapuram, India)

    Objective: To compare the characteristics of FMDs in children and adults Background: Functional movement disorders (FMDs) exhibit notable differences in phenomenology and treatment responses between…
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley